Back in June of 2019, the United States Preventive Services Task Force (“USPSTF”) released an A-rated recommendation for HIV Preexposure Prophylaxis (“PrEP”). As a result, the Affordable Care Act’s preventive care rules...more
It might happen to you because you’re an adventuresome diner or traveler. Or because of where you were born, or the kind of work you do. Or because you engaged in risky sex, even long ago, or experimented with drugs, or had a...more
Last week, in a case being watched locally and nationally, the Massachusetts Supreme Judicial Court (“SJC”) ruled that local government approval is not required for the operation of a private needle exchange program and that...more
Recently, the Supreme Court of Canada had the opportunity to decide a specific issue with potentially large ramifications. In Endean v. British Columbia (Endean), the Court considered whether judges of the Canadian Superior...more
Californians have gotten an unpleasant taste of the policy complexities caused when Big Pharma sets sky-high prices for life-changing drugs: State health officials say they need to set aside $1 billion to pay for increasing...more
Those working in the pharmaceutical space are used to hearing complaints about the high costs of drugs, and patents often are blamed for allowing pharmaceutical companies to charge “too much” for their products. But are drug...more
In This Issue: - Hospital-Acquired Infections Hit Hospitals’ Bottom Line - Will a new treatment option for hepatitis C bring down health care costs? - Implementation of the Affordable Care Act -...more
Thirty patients sued Exeter Hospital in New Hampshire when they came down with hepatitis C. The infection was traced to a single hospital lab employee, David Kwiatkowski. (Needless to say, David is no longer with the...more